Omission of axillary lymph node dissection for breast cancer patients with three or more positive sentinel lymph nodes.
Saranya PrathibhaMcKenzie WhiteMadison KolbowJane Yuet Ching HuiDavid BrauerJacob AnkenyEric H JensenChristopher J LaRoccaSchelomo MarmorTodd M TuttlePublished in: Breast cancer research and treatment (2024)
Approximately one-third of patients with ≥ 3 positive SLNs do not undergo ALND; omission of ALND increased from 2018 to 2020. Studies assessing oncologic outcomes of patients with ≥ 3 positive SLNs who do and do not receive ALND are required.